REBECCA SWINT: Open Payments
NPI 1053629188 · WHITE OAK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 9 payments from 4 companies in 2025. Trend: 2023 $229 · 2024 $69 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $126 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: LOKELMA, JARDIANCE, FARXIGA, LEQVIO, CAMZYOS.
Industry payments across PA — which companies pay providers there.
